loading
Precedente Chiudi:
$75.45
Aprire:
$75.89
Volume 24 ore:
1.19M
Relative Volume:
0.61
Capitalizzazione di mercato:
$2.41B
Reddito:
$401.09M
Utile/perdita netta:
$32.64M
Rapporto P/E:
76.54
EPS:
0.94
Flusso di cassa netto:
$-120.51M
1 W Prestazione:
-0.32%
1M Prestazione:
+26.83%
6M Prestazione:
-58.40%
1 anno Prestazione:
-17.29%
Intervallo 1D:
Value
$71.50
$76.78
Intervallo di 1 settimana:
Value
$71.50
$80.00
Portata 52W:
Value
$55.00
$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Name
Nome
Transmedics Group Inc
Name
Telefono
(978) 552-0900
Name
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Name
Dipendente
584
Name
Cinguettio
@transmedics
Name
Prossima data di guadagno
2024-10-28
Name
Ultimi documenti SEC
Name
TMDX's Discussions on Twitter

Confronta TMDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
TMDX
Transmedics Group Inc
71.95 2.41B 401.09M 32.64M -120.51M 0.94
Medical Devices icon
ABT
Abbott Laboratories
134.92 234.01B 41.95B 13.40B 6.49B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
104.49 154.20B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
382.78 146.06B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
89.94 115.42B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
73.30 43.23B 5.72B 4.17B 490.10M 6.97

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-17 Downgrade JP Morgan Overweight → Neutral
2024-11-22 Downgrade Needham Buy → Hold
2024-10-29 Reiterato Needham Buy
2024-10-29 Reiterato Oppenheimer Outperform
2024-09-24 Iniziato Robert W. Baird Outperform
2024-08-21 Iniziato Needham Buy
2024-06-06 Iniziato Cantor Fitzgerald Overweight
2024-06-04 Iniziato Stephens Overweight
2024-03-28 Iniziato Piper Sandler Overweight
2023-07-19 Iniziato Robert W. Baird Outperform
2022-08-02 Aggiornamento JP Morgan Neutral → Overweight
2020-10-08 Downgrade JP Morgan Overweight → Neutral
2020-04-07 Iniziato Oppenheimer Outperform
2019-05-28 Iniziato Canaccord Genuity Buy
2019-05-28 Iniziato Cowen Outperform
2019-05-28 Iniziato JP Morgan Overweight
2019-05-28 Iniziato Morgan Stanley Equal-Weight
Mostra tutto

Transmedics Group Inc Borsa (TMDX) Ultime notizie

pulisher
07:16 AM

TMDX CLASS ACTION DEADLINE: TransMedics Group, Inc. Investors with Losses are Notified of Ongoing Lawsuit – Contact BFA Law by April 15 Deadline - GlobeNewswire Inc.

07:16 AM
pulisher
12:53 PM

Kirby McInerney LLP Reminds TransMedics Group, Inc. (TMDX) - GlobeNewswire

12:53 PM
pulisher
Feb 21, 2025

Lowey Dannenberg Notifies TransMedics Group, Inc. - GlobeNewswire

Feb 21, 2025
pulisher
Feb 21, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group - Markets Insider

Feb 21, 2025
pulisher
Feb 21, 2025

TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman - PR Newswire

Feb 21, 2025
pulisher
Feb 21, 2025

Lost Money on TransMedics Group, Inc. (TMDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 21, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics LawsuitTMDX - Morningstar

Feb 21, 2025
pulisher
Feb 20, 2025

TMDX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc. (TMDX) - GlobeNewswire Inc.

Feb 20, 2025
pulisher
Feb 20, 2025

ROSEN, SKILLED INVESTOR COUNSEL, Encourages TransMedics - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

TMDX FRAUD LAWSUIT: TransMedics Group Investors that Lost - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

TMDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Feb 20, 2025
pulisher
Feb 20, 2025

TRANSMEDICS GROUP, INC. (NASDAQ: TMDX) INVESTOR ALERT: - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

TransMedics Group, Inc. (NASDAQ:TMDX) Shares Purchased by Peregrine Capital Management LLC - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

(TMDX) Investment Analysis and Advice - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 19, 2025

Baillie Gifford & Co. Increases Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

NASDAQ: TMDX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against TransMedics Group, Inc. - The Malaysian Reserve

Feb 19, 2025
pulisher
Feb 19, 2025

TransMedics Group (TMDX) Expected to Announce Earnings on Monday - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - TradingView

Feb 19, 2025
pulisher
Feb 19, 2025

TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Feb 19, 2025
pulisher
Feb 19, 2025

TransMedics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - The Eastern Progress Online

Feb 19, 2025
pulisher
Feb 18, 2025

Lowey Dannenberg, P.C. is Investigating TransMedics Group, - GlobeNewswire

Feb 18, 2025
pulisher
Feb 18, 2025

TransMedics Group, Inc. Stockholder Notice: Shareholder - GlobeNewswire

Feb 18, 2025
pulisher
Feb 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming DeadlinesTMDX - PR Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

TMDX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. Investors - Business Wire

Feb 18, 2025
pulisher
Feb 18, 2025

TransMedics to Present at Upcoming March Investor Conferences - PR Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group - Business Wire

Feb 18, 2025
pulisher
Feb 18, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Feb 18, 2025
pulisher
Feb 18, 2025

TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Feb 18, 2025
pulisher
Feb 17, 2025

Short Interest in TransMedics Group, Inc. (NASDAQ:TMDX) Increases By 23.8% - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Gladstone Institutional Advisory LLC Makes New $615,000 Investment in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

TMDX INVESTOR NOTICE: TransMedics Group, Inc. Investors - GlobeNewswire

Feb 17, 2025
pulisher
Feb 17, 2025

ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, - GlobeNewswire

Feb 17, 2025
pulisher
Feb 17, 2025

TMDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Feb 17, 2025
pulisher
Feb 17, 2025

TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - PR Newswire

Feb 17, 2025
pulisher
Feb 17, 2025

TMDX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Feb 17, 2025
pulisher
Feb 16, 2025

Investor Alert: Robbins LLP Informs Stockholders of the TransMedics Group, Inc. Class Action - PR Newswire

Feb 16, 2025
pulisher
Feb 16, 2025

Janney Montgomery Scott LLC Purchases New Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

TransMedics Group, Inc.'s (NASDAQ:TMDX) 26% Jump Shows Its Popularity With Investors - Simply Wall St

Feb 16, 2025
pulisher
Feb 16, 2025

TMDX CLASS ACTION ALERT: Scorpion Capital Report Triggers - GlobeNewswire

Feb 16, 2025
pulisher
Feb 16, 2025

Yousif Capital Management LLC Purchases 1,652 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World

Feb 16, 2025
pulisher
Feb 16, 2025

Sapient Capital LLC Has $209,000 Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Feb 16, 2025
pulisher
Feb 15, 2025

TransMedics Group, Inc. (NASDAQ:TMDX) Receives $122.70 Average PT from Analysts - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Feb 15, 2025
pulisher
Feb 15, 2025

TMDX INVESTOR ALERT: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Feb 15, 2025
pulisher
Feb 15, 2025

TransMedics Group (NASDAQ:TMDX) Stock Price Down 6.8%Time to Sell? - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TransMedics - GlobeNewswire

Feb 14, 2025
pulisher
Feb 14, 2025

TMDX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Feb 14, 2025

Transmedics Group Inc Azioni (TMDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Transmedics Group Inc Azioni (TMDX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Khayal Tamer I
Chief Commercial Officer
Jan 07 '25
Sale
80.05
1,083
86,694
20,843
Khayal Tamer I
Chief Commercial Officer
Dec 02 '24
Option Exercise
13.28
1,084
14,396
21,927
Khayal Tamer I
Chief Commercial Officer
Dec 02 '24
Sale
86.40
1,084
93,658
20,843
Khayal Tamer I
Chief Commercial Officer
Nov 11 '24
Option Exercise
38.46
1,458
56,075
22,301
Khayal Tamer I
Chief Commercial Officer
Nov 11 '24
Sale
90.04
1,458
131,278
20,843
Basile Edward M
Director
Nov 05 '24
Option Exercise
28.12
6,750
189,810
7,482
Basile Edward M
Director
Nov 05 '24
Sale
83.55
6,750
563,994
732
Khayal Tamer I
Chief Commercial Officer
Nov 01 '24
Option Exercise
13.28
1,083
14,382
21,926
Khayal Tamer I
Chief Commercial Officer
Nov 01 '24
Sale
82.64
1,083
89,499
20,843
medical_devices ZBH
$104.83
price up icon 1.16%
medical_devices STE
$220.56
price down icon 0.10%
medical_devices PHG
$25.55
price up icon 2.08%
$88.78
price down icon 0.63%
$91.09
price down icon 1.09%
medical_devices EW
$73.30
price down icon 1.89%
Capitalizzazione:     |  Volume (24 ore):